ELAHERE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72903-853 -
Package NDC
72903-853-01 -
Application number
BLA761310 -
SPL ID
47f1c78d-c469-4cd7-926e-51ce5b2d26f5 -
SPL set ID
00c424b5-6ccd-48ab-9e88-1986451120e2 -
UNII
98DE7VN88D -
RxCUI
2621553 -
RxCUI
2621559
What the source publishes
- Labeler
- ImmunoGen, Inc.
- Active ingredients
- MIRVETUXIMAB SORAVTANSINE
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ELAHERE",
"splId": "47f1c78d-c469-4cd7-926e-51ce5b2d26f5",
"labels": [
{
"setId": "00c424b5-6ccd-48ab-9e88-1986451120e2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00c424b5-6ccd-48ab-9e88-1986451120e2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00c424b5-6ccd-48ab-9e88-1986451120e2"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "ImmunoGen, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "72903-853-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20221114"
}
],
"productId": "72903-853_47f1c78d-c469-4cd7-926e-51ce5b2d26f5",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "72903-853",
"deaSchedule": null,
"genericName": "MIRVETUXIMAB SORAVTANSINE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIRVETUXIMAB SORAVTANSINE",
"strength": "5 mg/mL"
}
],
"applicationNumber": "BLA761310",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221114",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"98DE7VN88D"
],
"rxcui": [
"2621553",
"2621559"
],
"spl_set_id": [
"00c424b5-6ccd-48ab-9e88-1986451120e2"
],
"manufacturer_name": [
"ImmunoGen, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72903-853_47f1c78d-c469-4cd7-926e-51ce5b2d26f5"